ArticleESMO gastrointestinal oncology2025

Pharmacological advances in cannabinoid-based therapies for pancreatic cancer: preclinical efficacy of CCL-106 and its epimers.

K P Ray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.